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http://dx.doi.org/10.1016/j.kjms.201
1607-551X/Copyright ª 2015, KaohsiuAbstract Many materials and techniques have been used to prevent and repair intra-abdominal
adhesions, but an effective solution has not been found. The aim of this study is to research the
effect of sugammadex on intra-abdominal adhesions in an experimentally induced intra-
abdominal adhesion model. Twenty-four female Wistar albino rats were included in the study.
The experimental animals were randomly divided into three groups: the sugammadex group
(Group SX, nZ 8), the control group (Group C, nZ 8), and the sham group (Group S, nZ 8). After
starvation for 1 night, the rats were injected with a 50 mg/kg intramuscular dose of ketamine and
a 5 mg/kg intramuscular dose of xylazine for anesthesia. The rats in the SX group were given 3 mL
sugammadex into the peritoneal cavity, while rats in the control group were given 3 mL 0.9% so-
dium chloride. In the sham group, the peritoneal cavity was opened, but no chemicals were
administered. All rats were sacrificed on the 10th postoperative day. The adhesions were staged
as 0, 1, 2, and 3 according to Evans et al.’s model. Our evaluation of macroscopic adhesion inten-
sity found statistically significant differences between the groups. The sugammadex group was
observed to have fewer adhesions in a statistically significant manner compared with the control
group (p < 0.05). In our experimental intra-abdominal adhesion model in rats, we observed that
sugammadex prevented postoperative intra-abdominal adhesions.
Copyright ª 2015, Kaohsiung Medical University. Published by Elsevier Taiwan LLC. All rights
reserved.eclare no conflicts of interest.
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H. S‚ahin et al.IntroductionPostoperative adhesions are frequently seen after
abdominal surgery [1,2]. It is estimated that >90% of all
surgical procedures may cause adhesions [3]. These ad-
hesions are a major clinical problem after surgery [3,4].
Intra-abdominal adhesions may cause many complications
such as intestinal obstruction, chronic abdominal pain,
infertility, and extended hospital stays. Additionally,
nearly a third of these patients require repeated opera-
tion under emergency conditions [5]. Studies have deter-
mined that the real cause of mortality and morbidity in
60e70% of patients with intra-abdominal adhesions is in-
testinal obstruction [6e8]. Many materials and techniques
have been used to prevent and repair the problem, but an
effective solution has not been found. Recent studies
have focused on the formation of a mechanical barrier
between peritoneal surfaces. To prevent postoperative
peritoneal adhesions, the most frequently used methods
involve administering a variety of fluids and drugs within
the peritoneum. Many agents such as phospholipase in-
hibitors, dextrans, corticosteroids, phospholipids, and
methylene blue have been tested according to literature
[9,10]. For this mechanical barrier, gelatin-like fluids with
high viscosity have been found to be more effective
because these high-viscosity fluids form a layer preventing
surfaces in the area of the peritoneum from contacting
surrounding tissue and preventing adhesions [11,12].
Among prophylactic solutions used to prevent adhesions,
the most frequently used agent is a high-molecular weight
dextran solution, which covers surfaces and has a silico-
nizing effect that prevents contact between injured sur-
faces. A new agent, called sugammadex, is a water-
soluble glucose polymer with a g-cyclodextrin structure.
Sugammadex selectively binds to nondepolarizing blockers
with a steroid structure, like rocuronium, used as a muscle
relaxant during general anesthesia. It safely and quickly
reverses the deep neuromuscular blockage induced by
rocuronium [13e16].
The aim of this study is to research the effect of
sugammadex on intra-abdominal adhesions in an experi-
mentally induced intra-abdominal adhesion model.
Methods
Required permissions for the study were obtained from
Canakkale Onsekiz Mart University Experimental Animals
Ethics Committee (2014/03-01; C¸anakkale, Turkey). The
study was completed in the Canakkale Onsekiz Mart Uni-
versity Experimental Animals Research Center in Turkey.
Experimental groups
Twenty-four female Wistar albino rats (mean weight:
300  25 g; mean age: 5 months) were included in the
study. The experimental animals were randomly divided
into three groups: the sugammadex group (Group SX,
n Z 8), the control group (Group C, n Z 8), and the sham
group (Group S, n Z 8).
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After starvation for 1 night, the rats were injected with a
50 mg/kg intramuscular (IM) dose of ketamine and a 5 mg/
kg IM dose of xylazine for anesthesia. After the midline of
the abdomen was shaved, antisepsis was provided with
povidone iodine. With a 3 cm vertical midline incision, the
peritoneal cavity was entered. The cecum and terminal
ileum were found and placed on a damp gauze pad. With a
dry gauze pad, the cecum and 2 cm of the terminal ileum
were scraped. This procedure continued until the petechial
hemorrhage foci were observed (scraping model) [17].
Later, rats in the SX group (nZ 8) were given 3 mL (300 mg)
sugammadex (Bridion, Schering-Plough Corporation, Oss,
The Netherlands) into the peritoneal cavity, while rats in
the control group (Group C, n Z 8) were given 3 mL 0.9%
sodium chloride. Rats in the sham group (Group S, n Z 8)
only had a 3 cm vertical incision completed and the peri-
toneal cavity entered, but no chemicals were administered
to these animals. The incision was closed with the contin-
uous stitch technique using propylene thread. After the
24 hour postoperative check, the rats were allowed to
feed. All rats were given a 50 mg/kg IM dose of ketamine
and a 5 mg/kg IM dose of xylazine for sufficient anesthesia
on the 10th postoperative day and were sacrificed. To see
the adhesions and to determine the correct staging, the
peritoneal cavity was entered through an “inverse U”
incision. Without disturbing the flap adhesions on the
abdominal anterior wall, the abdominal anterior wall was
pulled to caudal. Evans et al.’s [18] scoring was performed
by general surgeons who were blinded to group allocation.
The adhesions were staged as 0, 1, 2, and 3 according to
Evans’ model (Table 1).
Statistical analysis
All statistical analysis was performed using SPSS 15 (SPSS
Inc., Chicago, IL, USA) statistical software for Windows. A
nonparametric test, called the Chi-square test, was used to
compare data from the sugammadex and control groups. A
p value < 0.05 was considered significant.
Results
Our evaluation of macroscopic adhesion intensity showed
statistically significant differences between the groups.
When compared in terms of adhesion score 0, a limited
significant difference was observed between the sugamma-
dex group and the control group (pZ 0.05). When compared
in terms of adhesion score 1, a significant difference was
observed between the sugammadex group and the control
group (p Z 0.02). When compared in terms of adhesion
score 2, a significant difference was observed between the
sugammadex group and the control group (p Z 0.03).
Finally, when compared in terms of adhesion score 3, a
limited significant difference was also observed between
the sugammadex group and the control group (p Z 0.05).
In Table 2 the evaluation of macroscopic adhesions ac-
cording to Evans et al.’s [18] model indicates that the
Figure 1. Grade 0 adhesion.
Figure 2. Grade 1 adhesion.
Table 1 Evans adhesion scoring.
Score Description
0 No adhesions
1 Spontaneously separating
adhesion
2 Separation of adhesion with
traction
3 Separation of adhesion with a
sharp dissection
Sugammadex and peritoneal adhesion prevention 465sugammadex group had three score 0 adhesions (Figure 1),
four score 1 adhesions (Figure 2), and one score 2 adhesion
(Figure 3), whereas the control group had five score 2 ad-
hesions (Figure 3) and three score 3 (Figure 4) adhesions. In
the experimental animals of the sham group, only one was
observed to have a score 1 (Figure 2) adhesion. We
observed an adhesion to the abdominal wall of a single rat
in the control group (Figure 4).
Discussion
In this study of an experimental intra-abdominal adhesion
model in rats, we observed that sugammadex prevented
intra-abdominal adhesions.
Injury of peritoneal surfaces by factors such as me-
chanical, lavage, thermal, infection, and foreign bodies
begin events that result in the formation of adhesions.
Injury of peritoneal mesothelial cells causes a release of
thromboplastin, activating the clotting mechanism, which
results in the formation of fibrin. Extreme fibrin production
or weakened peritoneal plasminogen activator activation
means the fibrin is not removed from the environment and
forms a matrix for the development of adhesions [19e21].
In the damaged peritoneal region, there is an exudate rich
in fibrin that forms a band between surfaces in contact. The
fibrin bands and the spaces between these fibrin bands
form a matrix rich in hyaluronic acid, creating an appro-
priate environment for collagen synthesis, which results in
an adhesion [19e21]. Agents used to prevent adhesions are
effective on mechanisms at any stage of the activated
peritoneal damage and resulting adhesion formation
[19e21]. Many different materials and methods have been
used to prevent postoperative adhesions, but their clinical
use is limited because most have been unsuccessful
[22e24]. Preventing the accumulation of fibrin fromTable 2 The number of rats with different grades of ad-
hesions in the three groups.
Adhesion scores Group SX
n Z 8
Group C
n Z 8
Group S
n Z 8
p
Score 0 3 0 7 0.05
Score 1 4 0 1 0.02
Score 2 1 5 0 0.03
Score 3 0 3 0 0.05
Group C Z control group; Group S Z sham group; Group SX Z
sugammadex group.
Figure 3. Grade 2 adhesion.
Figure 4. Grade 3 adhesion.
466 H. S‚ahin et al.peritoneal exudate has been attempted with sodium cit-
rate, heparin, and other anticoagulants. A variety of fibri-
nolitic agents, salts like sodium risonilate, and mechanical
peritoneal lavage have been used to remove accumulated
fibrin [25,26].
Dextran is a water-soluble glucose polymer used as a
plasma expander. Among prophylactic solutions, the most
commonly used to prevent adhesions is a high molecular
weight dextran solution.
In an experimental study [27] when the effects of chi-
tosane and a chitosane-dextran (CD) gel mixture on intra-
abdominal adhesions were compared, CD gel prevented
intra-abdominal adhesions better than chitosane. While CD
gel prevented intra-abdominal adhesions, it was deter-
mined to inhibit fibroblast proliferation and physically
separate the injured peritoneal surfaces.
Sugammadex is a compound from the cyclic oligosac-
charide family. It is a medication that binds to steroid-
structured nondepolarizing muscle relaxants and its use is
continually increasing. Sugammadex reverses paralysis by
coating free-circulating nondepolarizing muscle relaxants.
It is superior to anticholinesterase because it reverses
neuromuscular blockage rapidly and effectively, and re-
duces the recovery time [28]. Our review of the literature
found no studies using sugammadex, which resembles
dextran in structure, to prevent intra-abdominal adhesions.
Sugammadex is viscous, allowing it to coat the damaged
peritoneal surfaces with a siliconizing effect, and we
believe this action will prevent the damaged surfaces from
coming into contact with each other. However, similar to
dextran [29], it may result in temporary acid formation,
causing the intestines to float in this acid. We believe that
with these effects sugammadex will prevent adhesions in
the early period.
Different classifications are used to stage intra-
abdominal adhesions. The stages described by Evans et al.
[18] classify adhesions as 0, 1, 2 or 3 based on severity of
adhesions of the serosal surfaces. The severity of adhesions
plays a large role in the development of complications
linked to postoperative peritoneal adhesions. As a result of
this realistic aspect and its practical application, our studyused Evans et al.’s [18] model to stage adhesions. When
compared with the control group in our study, the sugam-
madex group was observed to have significantly fewer
postoperative intra-abdominal adhesions. High viscosity
sugammadex is not absorbed by the peritoneal lymphatics,
so it stays in the peritoneal cavity for a long time, pre-
venting damaged peritoneal surfaces from touching and,
we believe, preventing adhesion of these surfaces.
Postoperative ileus cases due to the development of
intra-abdominal adhesions is one possible complication,
which is encountered more frequently after repeated sur-
gery. As a result, we found that increasing the incidence of
ileus condition further intensifies the development of the
adhesion [25]. When compared in terms of adhesion score
2, a significant difference was observed between the
sugammadex group and control group. When compared in
terms of adhesion score 3, a limited significant difference
was observed between the sugammadex group and control
group. Therefore, we believe that sugammadex is impor-
tant for reducing the degree of prevention of postoperative
adhesions, as well as intra-abdominal adhesions.
In conclusion, we observed that sugammadex prevented
postoperative intra-abdominal adhesions in our experi-
mental intra-abdominal adhesion model in rats. However, a
variety of clinical studies are required for sugammadex to
be used to prevent postoperative peritoneal adhesion in
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